We are currently experiencing technical difficulties with logging into the network, causing some users to not have access. Please contact us at daa@daa.duke.edu if you are unable to log in so we can resolve the issue.
We are currently experiencing technical difficulties with logging into the network, causing some users to not have access. Please contact us at daa@daa.duke.edu if you are unable to log in so we can resolve the issue.

Science & Society "Coronavirus Conversations": On the Ground: Inside the Covid-19 Vaccine Trials

View other events

Date: Thursday, November 5, 2020 | 12:30 am EST

Location:  Zoom Meeting (Event ID will be sent to RSVP list)
304 Research Drive
Durham, North Carolina  27708
United States


Learn more & Register

Coronavirus Conversations
Inside the COVID-19 Vaccine Trials


Thursday, November 5th, 4:00 PM (EDT), on Zoom  
 

Co-Hosted with the Duke Global Health Institute, the Harvard Petrie-Flom Center For Bioethics, and the Yale School of Public Health.

Ten months into the pandemic, we are making rapid progress toward developing a safe and effective COVID-19 vaccine, with several vaccines in Phase 3 trials in the US alone.  Despite this remarkable speed, concerned citizens and members of the medical and public health communities naturally have questions: What does it mean about overall safety and effectiveness that some projects have been paused to ensure the safety and health of vaccine trial participants? Who has been included in the trial process, and how representative are they of our society? When the first vaccines are found to be safe and effective, how effective can we expect them to be, based on current indications?

Join Duke Science & Society and our guests, who are overseeing COVID-19 vaccine trials for Moderna and Pfizer, in a discussion of how the COVID-19 vaccine trials are progressing in the U.S., what current indications are about their safety and efficacy, and when we can expect initial approvals for early or limited use.

Panelists:

Cindy Gay, M.D., M.P.H.; Principal Investigator, University of North Carolina site of the Moderna SARS-COV-2 vaccine trial, Associate Professor of Medicine, Division of Infectious Diseases; Medical Director, UNC HIV Cure Center

Emmanuel (Chip) Walter, M.D.; Principal Investigator, Duke University site of the Pfizer SARS-COV-2 vaccine trial, Professor of Pediatrics, Affiliate, Duke Global Health Institute, Member in the Duke Clinical Research Institute, Member of the Duke Human Vaccine Institute

Moderator:

Nita Farahany, J.D., Ph.D.; Duke University; Director, Duke Initiative For Science & Society; Professor of Law and Philosophy, Duke University

information

Related Groups

Duke Science Policy Network

Duke Science Policy Network engages, connects, and celebrates alumni and students focused on science, policy, and ethics.

DukeEngage Alumni

The DukeEngage affinity group connects, engages, and provides leadership opportunities to Duke students and alumni who have participated in DukeEngage and share a passion for civic engagement.